Prostate Cancer Survivorship Care in the Veterans Health Administration

Overview

Journal Fed Pract

Specialty Health Services

Date 2018 Oct 30

PMID 30369784

Citations 8

Authors

Ted A Skolarus

Sarah T Hawley

Affiliations

Soon will be listed here.

Abstract

The burden of prostate cancer among Veterans is substantial with over 200,000 survivors and 12,000 new diagnoses annually. Most men live with rather than die from this common and expensive disease making prostate cancer survivorship care especially important. In addition, the symptom burden after prostate cancer treatment can be substantial, last well into survivorship and lead to reduced quality of life and greater use of services. For these reasons, it is increasingly recognized that cancer survivorship care is similar to chronic disease management in requiring a combination of primary care providers and cancer specialists to deliver care over long periods of time. Because of its leadership in chronic disease care and the proportion of older men served, the Veterans Health Administration (VHA) is well positioned to become one of the national leaders in prostate cancer survivorship care. However, best practices and portfolios of quality indicators for prostate cancer survivorship care remain underdeveloped. More broadly, there is a limited consensus about who (primary care providers or prostate cancer specialists - urologists, radiation and medical oncologists) has primary responsibility for prostate cancer surveillance, and who manages the often substantial and lingering treatment-related side effects. Unclear roles and regional variation in the VHA cancer specialist workforce also complicate delivery of quality survivorship care. Ultimately, the design and implementation of tools to facilitate the delivery of optimal cancer survivorship care in VHA rests upon understanding how responsibility for survivorship care is managed and the barriers to quality survivorship care. Due to the expanding population of Veteran prostate cancer survivors, improving their quality of survivorship care through effective use of the VHA's provider workforce and latest telemedicine initiatives has potential to transform the national efficiency and effectiveness of cancer specialty care delivery.

Citing Articles

Military service and health-related quality of life among gay and bisexual prostate cancer survivors: Results from the study.

Bates A, Mitteldorf D, Rosser B, Wheldon C, Polter E, Ross M BMJ Mil Health. 2024; .

PMID: 38548328 PMC: 11436476. DOI: 10.1136/military-2023-002649.

Improving Bone Health in Patients with Metastatic Prostate Cancer with the Use of Algorithm-Based Clinical Practice Tool.

Sahu K, Johnson E, Butler K, Li H, Boucher K, Gupta S Geriatrics (Basel). 2022; 7(6).

PMID: 36547269 PMC: 9778212. DOI: 10.3390/geriatrics7060133.

Harris A, Yasuda M, Wu M, Deirmenjian J, Farooq A, Baldea K Fed Pract. 2021; 38(Suppl 3):S52-S56.

PMID: 34733096 PMC: 8560122. DOI: 10.12788/fp.0147.

Bone Health in Patients With Prostate Cancer: An Evidence-Based Algorithm.

Johnson E, Butler K, Gupta S Fed Pract. 2021; 38(Suppl 3):S20-S26.

PMID: 34733092 PMC: 8560120. DOI: 10.12788/fp.0155.

Factors Associated with Osteoporosis Management Among Veterans Who Received Androgen Deprivation Therapy for Prostate Cancer.

Solimeo S, Lund B, McCoy K, Vaughan Sarrazin M, Hoffman R J Gen Intern Med. 2021; 36(10):3270-3272.

PMID: 33483816 PMC: 8481523. DOI: 10.1007/s11606-020-06418-5.

References

Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A . Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2009; 28(1):126-31. DOI: 10.1200/JCO.2009.24.2180. View

Skolarus T, Miller D, Zhang Y, Hollingsworth J, Hollenbeck B . The delivery of prostate cancer care in the United States: implications for delivery system reform. J Urol. 2010; 184(6):2279-84. DOI: 10.1016/j.juro.2010.08.002. View

Wilt T, Shamliyan T, Taylor B, MacDonald R, Kane R . Association between hospital and surgeon radical prostatectomy volume and patient outcomes: a systematic review. J Urol. 2008; 180(3):820-8. DOI: 10.1016/j.juro.2008.05.010. View

Odisho A, Fradet V, Cooperberg M, Ahmad A, Carroll P . Geographic distribution of urologists throughout the United States using a county level approach. J Urol. 2008; 181(2):760-5. DOI: 10.1016/j.juro.2008.10.034. View

Sales A, Lapham G, Squires J, Hutchinson A, Almenoff P, Sharp N . Organizational factors associated with decreased mortality among Veterans Affairs patients with an ICU stay. Comput Inform Nurs. 2011; 29(9):496-501. DOI: 10.1097/NCN.0b013e3182148c47. View

Baumann F, Zopf E, Bloch W . Clinical exercise interventions in prostate cancer patients--a systematic review of randomized controlled trials. Support Care Cancer. 2011; 20(2):221-33. DOI: 10.1007/s00520-011-1271-0. View

Miller D, Sanda M, Dunn R, Montie J, Pimentel H, Sandler H . Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005; 23(12):2772-80. DOI: 10.1200/JCO.2005.07.116. View

Bolla M, Collette L, Blank L, Warde P, Dubois J, Mirimanoff R . Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet. 2002; 360(9327):103-6. DOI: 10.1016/s0140-6736(02)09408-4. View

Helfrich C, Blevins D, Smith J, Kelly P, Hogan T, Hagedorn H . Predicting implementation from organizational readiness for change: a study protocol. Implement Sci. 2011; 6:76. PMC: 3157428. DOI: 10.1186/1748-5908-6-76. View

10.

Francis J, OConnor D, Curran J . Theories of behaviour change synthesised into a set of theoretical groupings: introducing a thematic series on the theoretical domains framework. Implement Sci. 2012; 7:35. PMC: 3444902. DOI: 10.1186/1748-5908-7-35. View

11.

Jacobs L, Palmer S, Schwartz L, DeMichele A, Mao J, Carver J . Adult cancer survivorship: evolution, research, and planning care. CA Cancer J Clin. 2009; 59(6):391-410. DOI: 10.3322/caac.20040. View

12.

Fishbein M, Ajzen I . Theory-based behavior change interventions: comments on Hobbis and Sutton. J Health Psychol. 2004; 10(1):27-31. DOI: 10.1177/1359105305048552. View

13.

Gagliardi A, Brouwers M, Palda V, Lemieux-Charles L, Grimshaw J . How can we improve guideline use? A conceptual framework of implementability. Implement Sci. 2011; 6:26. PMC: 3072935. DOI: 10.1186/1748-5908-6-26. View

14.

McDermott K, Helfrich C, Sales A, Rumsfeld J, Ho P, Fihn S . A review of interventions and system changes to improve time to reperfusion for ST-segment elevation myocardial infarction. J Gen Intern Med. 2008; 23(8):1246-56. PMC: 2517976. DOI: 10.1007/s11606-008-0563-7. View

15.

Grimshaw J, Eccles M, Steen N, Johnston M, Pitts N, Glidewell L . Applying psychological theories to evidence-based clinical practice: identifying factors predictive of lumbar spine x-ray for low back pain in UK primary care practice. Implement Sci. 2011; 6:55. PMC: 3125229. DOI: 10.1186/1748-5908-6-55. View

16.

Hysong S, Teal C, Khan M, Haidet P . Improving quality of care through improved audit and feedback. Implement Sci. 2012; 7:45. PMC: 3462705. DOI: 10.1186/1748-5908-7-45. View

17.

Ferrer M, Suarez J, Guedea F, Fernandez P, Macias V, Marino A . Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008; 72(2):421-32. DOI: 10.1016/j.ijrobp.2007.12.024. View

18.

Arora S, Kalishman S, Thornton K, Dion D, Murata G, Deming P . Expanding access to hepatitis C virus treatment--Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology. 2010; 52(3):1124-33. PMC: 3795614. DOI: 10.1002/hep.23802. View

19.

Goode P, Burgio K, Johnson 2nd T, Clay O, Roth D, Markland A . Behavioral therapy with or without biofeedback and pelvic floor electrical stimulation for persistent postprostatectomy incontinence: a randomized controlled trial. JAMA. 2011; 305(2):151-9. PMC: 5557087. DOI: 10.1001/jama.2010.1972. View

20.

Damschroder L, Hagedorn H . A guiding framework and approach for implementation research in substance use disorders treatment. Psychol Addict Behav. 2011; 25(2):194-205. DOI: 10.1037/a0022284. View